Cardiac surgery is the process performed to cure the heart tissue defects, for grafting, or for replacement of heart tissues in case of damage. There are two major types of heart surgeries-closed and open. Aging populations, elevating rates of obesity, poor nutrition, and health stressor majorly drive the market growth. In addition, rapid technological advancement, increase in awareness of the population, and demand for minimally invasive procedures also fuel the market growth. However, excessive cost of cardiac surgical devices and their maintenance is expected to restrain the growth of the market during the forecast period. The global cardiac surgical devices market is accounted for $1,700 million in 2016, and is estimated to reach $2,124 million by 2022, growing at a CAGR of 3.2% during the analysis period (2017-2023).
The market is segmented on the basis of product type, application, age-group, and geography. By product type, the market is categorized into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Applications covered in the study include congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and others. Based on age group, it is classified into new-born, infant, children, and adults. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS:
The study provides an in-depth analysis of the global cardiac surgical devices market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
Cardiac Surgical Devices Market Key Segments:
By Product Type
Beating Heart Surgery Systems
Cardiopulmonary Bypass Equipment
Cardiac Ablation Devices
Perfusion Disposables
By Application
Congenital Heart Defects
Cardiac Arrhythmia
Coronary Heart Disease
Congestive Heart Failure
Other Applications
By Age Group
New-born (0-30 days)
Infant (31 days-1 year)
Children (1-18 years)
Adult (18+ years)
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Others
Asia Pacific
Japan
China
India
Others
LAMEA
Latin America
Middle East
Africa
List of players profiled in the report
Edwards Life Science Corporation
Medtronic Inc.
Getinge Group
Atrion Corporation
Abbott Laboratories
Sorin S.P.A.
Terumo Medical Corporation
Boston Scientific Corporation
Cook Medical
Angiodynamics, Inc.
List of other players (These companies are not profiled in the report and same can be done on demand)
C. R. Bard, Inc.
Trinity Biotech
Abiomed, Inc.
Cardinal Health
CyberHeart Incorporated
MedWaves Incorporated
Transmedics, Inc.
